SCHMID Group N.V. Provides Second Quarter 2026 Business Update and Full Year 2026 Order Guidance Update

SCHMID reported Q2 2026 order intake of €30.7m and revenue of €27.7m, with the order backlog rising to €54.8m. Management lifted full-year 2026 order intake guidance from ~€114m to €125–€150m (vs. prior outlook) while reiterating >€100m revenue and >12% full-year EBITDA margin, though H1 EBITDA margin is expected to be significantly lower than 12%. The company also closed a $20m convertible notes issuance, targeting working-capital needs tied to faster order intake and capex for moving from rented to an owned China manufacturing plant.

Analysis

The near-term setup is less about demand and more about financing elasticity. A small-cap industrial name raising convert capital while ramping owned capacity usually trades as a working-capital story first: if receivables and inventory absorb cash faster than revenue converts, the equity gets re-rated on dilution risk even when orders improve. In the next 1-3 months, the market will care most about whether backlog actually turns into billable revenue without another financing step.

Second-order, the capacity move in China can be a double-edged sword. If utilization ramps cleanly, the company gains gross-margin leverage and tighter control versus outsourced manufacturing; if orders normalize, it risks sitting on fixed-cost overhead in a cyclical capex niche. That creates a brittle setup for competitors in PCB/substrate equipment: a stronger order book from one player can signal broader restart in the supply chain, but it can also pressure peers on price if they chase the same customer budgets.

Contrarian view: the consensus may be overweighting order intake and underweighting balance-sheet quality. For a company of this size, the convert matters as much as the backlog because it can cap upside until investors see audited half-year numbers, cash conversion, and no further equity issuance. The thesis is falsified if August results show EBITDA tracking to guidance with working capital under control and backlog converting into cash rather than just orders.

Key Decisions for Investors

• No fresh long in SHMD before the August 25 half-year report; treat the stock as a financing-overhang trade until audited EBITDA, cash conversion, and working-capital usage are visible.
• If already long, use any post-announcement strength over the next 1-2 sessions to trim exposure; the convert increases dilution risk and can mute upside unless revenue recognition accelerates materially.
• Watch SHMD as a catalyst alert, not a conviction trade: a clean August print with stable cash burn would justify a tactical long; a miss on margin or another funding need would be a clear exit signal.
• Relative-value bias: prefer broader semiconductor/electronics capex exposure over SHMD until execution is proven, because this name’s upside is more constrained by balance-sheet mechanics than by sector demand.